Artifact4U Recall
← Search all records

FDA recall announcement

Lipofit Extreme 2.0 Fat Burner Dietary Supplement recall 2026

Ana Salazar Modela Tu Cuerpo Inc. announced a recall of Lipofit Extreme 2.0 Fat Burner Dietary Supplement. FDA lists the reason as: Undeclared Fluoxetine and 2,4-Dinitrophenol (DNP)

A specific recall was announced.

Undeclared Fluoxetine and 2,4-Dinitrophenol (DNP)

FDA publish date
August 31, 2026
Company
Ana Salazar Modela Tu Cuerpo Inc.
Product
Lipofit Extreme 2.0 Fat Burner Dietary Supplement
Last checked
September 23, 2026
NDC / identifier
No specific identifier listed in this announcement
Affected lot(s)
No specific lot listed for this clarification

What the FDA announcement says

Undeclared Fluoxetine and 2,4-Dinitrophenol (DNP)

Read the original FDA recall announcement →

What to check on the package

  1. Confirm the exact product and brand name.
  2. Compare the manufacturer or distributor.
  3. Match the NDC or product identifier.
  4. Match the lot or code exactly; a drug name alone is not enough.

What to do

Compare the exact product, company, identifier, and lot with the FDA announcement. Follow the recalling company or FDA instructions for affected products.

Do not stop or change a prescribed medication based only on this page. Contact a pharmacist, prescriber, or the recalling company for instructions specific to your product.

Related FDA enforcement records

No matching record was found in the current openFDA enforcement snapshot. FDA announcements can appear before a classified enforcement record reaches the dataset.

Search all records for Lipofit Extreme 2.0 Fat Burner Dietary Supplement →

Source and limitations

This server-rendered page summarizes an FDA source and the openFDA enforcement snapshot last checked on September 23, 2026. It is not an FDA service and does not provide individual medical advice.